» Articles » PMID: 24551133

A Fluorescence-coupled Assay for Gamma Aminobutyric Acid (GABA) Reveals Metabolic Stress-induced Modulation of GABA Content in Neuroendocrine Cancer

Overview
Journal PLoS One
Date 2014 Feb 20
PMID 24551133
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Pathways involved in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA) have been implicated in the pathogenesis of high grade neuroendocrine (NE) neoplasms as well as neoplasms from a non-NE lineage. Using The Cancer Genome Atlas, overexpression of the GABA synthetic enzyme, glutamate decarboxylase 1 (GAD1), was found to be associated with decreased disease free-survival in prostate adenocarcinoma and decreased overall survival in clear cell renal cell carcinomas. Furthermore, GAD1 was found to be expressed in castrate-resistant prostate cancer cell lines, but not androgen-responsive cell lines. Using a novel fluorescence-coupled enzymatic microplate assay for GABA mediated through reduction of resazurin in a prostate neuroendocrine carcinoma (PNEC) cell line, acid microenvironment-induced stress increased GABA levels while alkaline microenvironment-induced stress decreased GABA through modulation of GAD1 and glutamine synthetase (GLUL) activities. Moreover, glutamine but not glucose deprivation decreased GABA through modulation of GLUL. Consistent with evidence in prokaryotic and eukaryotic organisms that GABA synthesis mediated through GAD1 may play a crucial role in surviving stress, GABA may be an important mediator of stress survival in neoplasms. These findings identify GABA synthesis and metabolism as a potentially important pathway for regulating cancer cell stress response as well as a potential target for therapeutic strategies.

Citing Articles

Integrated analysis identifies GABRB3 as a biomarker in prostate cancer.

Chen J, Chang C, Huang S, Huang C, Yu C, Lin V BMC Med Genomics. 2024; 17(1):41.

PMID: 38287309 PMC: 10826114. DOI: 10.1186/s12920-024-01816-8.


Discovery of GABA Aminotransferase Inhibitors via Molecular Docking, Molecular Dynamic Simulation, and Biological Evaluation.

Yasir M, Park J, Lee Y, Han E, Park W, Han J Int J Mol Sci. 2023; 24(23).

PMID: 38069313 PMC: 10707509. DOI: 10.3390/ijms242316990.


GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer.

Wan L, Liu Y, Liu R, Mao W Cancer Cell Int. 2023; 23(1):255.

PMID: 37904122 PMC: 10617133. DOI: 10.1186/s12935-023-03093-4.


The Long Noncoding RNA Cytoskeleton Regulator RNA (CYTOR)/miRNA-24-3p Axis Facilitates Nasopharyngeal Carcinoma Progression by Modulating GAD1 Expression.

Du J, Yu W, Peng L, Zhang T J Oncol. 2023; 2023:6027860.

PMID: 36814556 PMC: 9940962. DOI: 10.1155/2023/6027860.


A GC-MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice.

Cui C, Zhu L, Wang Q, Liu R, Xie D, Guo Y Heliyon. 2022; 8(7):e09869.

PMID: 35855991 PMC: 9287194. DOI: 10.1016/j.heliyon.2022.e09869.


References
1.
Zhang , Chung , OLDENBURG . A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 2000; 4(2):67-73. DOI: 10.1177/108705719900400206. View

2.
Kobayashi S, Millhorn D . Hypoxia regulates glutamate metabolism and membrane transport in rat PC12 cells. J Neurochem. 2001; 76(6):1935-48. DOI: 10.1046/j.1471-4159.2001.00214.x. View

3.
DeBerardinis R, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S . Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A. 2007; 104(49):19345-50. PMC: 2148292. DOI: 10.1073/pnas.0709747104. View

4.
Xue Q, Wang L, Jiang W . A novel label-free cascade amplification strategy based on dumbbell probe-mediated rolling circle amplification-responsive G-quadruplex formation for highly sensitive and selective detection of NAD+ or ATP. Chem Commun (Camb). 2013; 49(26):2640-2. DOI: 10.1039/c3cc39064k. View

5.
Smart T, Hosie A, Miller P . Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist. 2004; 10(5):432-42. DOI: 10.1177/1073858404263463. View